Back
FormFactor 10K Form
Buy
53
FORM
FormFactor
Last Price:
$32.01
Seasonality Move:
7.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | FORM/FormFactor Quarterly |
2023-11-07 | 10Q | FORM/FormFactor Quarterly |
2023-08-08 | 10Q | FORM/FormFactor Quarterly |
2023-05-09 | 10Q | FORM/FormFactor Quarterly |
2022-11-01 | 10Q | FORM/FormFactor Quarterly |
2022-08-02 | 10Q | FORM/FormFactor Quarterly |
Receive FORM News And Ratings
See the #1 stock for the next 7 days that we like better than FORM
FORM Financial Statistics
Sales & Book Value
Annual Sales: | $763.6M |
---|---|
Cash Flow: | $28.3M |
Price / Cash Flow: | 31.75 |
Annual Sales: | $12.29 |
Price / Book: | 2.62 |
Profitability
EPS (TTM): | 0.89000 |
---|---|
Net Income (TTM): | $69.6M |
Gross Margin: | $307.9M |
Return on Equity: | 7.43% |
Return on Assets: | 6.13% |
FormFactor Earnings Forecast
Key FormFactor Financial Ratios
-
The Gross Profit Margin over the past 25 years for FORM is 40.33%.
-
The Selling, General & Administrative Expenses for FORM have been equal to 18.57% of Gross Profit Margin.
-
The Research & Development expenses have been 15.97% of Revenue.
-
The Interest Expense is 0.60% of Operating Income.
-
The Net Earning history of FORM is 9.12% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 15 years.
FormFactor Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | FORM |
CUSIP: | 346375 |
Website: | formfactor.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 4.61 |
Quick Ratio: | 3.54 |
Price-to-Earnings
Trailing P/E Ratio: | 35.96 |
---|---|
Forward P/E Ratio: | 18.74 |
FORM Technical Analysis vs Fundamental Analysis
Buy
53
FormFactor (FORM)
is a Buy
Is FormFactor a Buy or a Sell?
-
FormFactor stock is rated a BuyThe current FormFactor [FORM] share price is $32.00. The Score for FORM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.